Novartis-Intas Ranibizumab Settlement Sets Liability For Breach
This article was originally published in Scrip
Executive Summary
Novartis and Intas Pharmaceuticals Ltd have reached an out-of-court settlement pertaining to their dispute concerning ranibizumab.